Sign In
Buy CARA
$5.32
+0 (+0%)
At Close: Jul 14, 2025
Cara Therapeutics Inc (NASDAQ:CARA) CEO Sells $98,774.88 in Stock
11:28am, Friday, 24'th Apr 2020
Cara Therapeutics Inc (NASDAQ:CARA) CEO Derek T. Chalmers sold 6,348 shares of the stock in a transaction that occurred on Tuesday, April 21st. The stock was sold at an average price of $15.56, for a
A visual representation of SKECHERS (SKX) Q1 2020 earnings results | AlphaStreet
08:29pm, Thursday, 23'rd Apr 2020
SKECHERS USA, Inc. (NYSE:SKX) reported first quarter 2020 earnings results today.
Derek T. Chalmers Sells 6,348 Shares of Cara Therapeutics Inc (NASDAQ:CARA) Stock
10:06am, Thursday, 23'rd Apr 2020
Cara Therapeutics Inc (NASDAQ:CARA) CEO Derek T. Chalmers sold 6,348 shares of Cara Therapeutics stock in a transaction dated Tuesday, April 21st. The shares were sold at an average price of $15.56, f
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald CARA
11:46am, Wednesday, 22'nd Apr 2020
Cara Therapeutics price target raised to $34 from $26 at Cantor Fitzgerald Cantor Fitzgerald CARA
Jeffrey L. Ives Sells 2,500 Shares of Cara Therapeutics Inc (NASDAQ:CARA) Stock
10:42am, Wednesday, 22'nd Apr 2020
Cara Therapeutics Inc (NASDAQ:CARA) Director Jeffrey L. Ives sold 2,500 shares of the firm’s stock in a transaction dated Tuesday, April 21st. The shares were sold at an average price of $16.00, for
Cantor Fitzgerald Reiterates Overweight on Cara Therapeutics, Raises Price Target to $34
10:39am, Wednesday, 22'nd Apr 2020Analysts Offer Insights on Healthcare Companies: Biohaven Pharmaceutical Holding Co (BHVN) and Cara Therapeutics (CARA)
10:17am, Wednesday, 22'nd Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biohaven Pharmaceutical Holding Co (BHVN) and Cara
Analysts Offer Insights on Healthcare Companies: Biohaven Pharmaceutical Holding Co (NYSE: BHVN) and Cara Therapeutics (NASDAQ: CARA)
10:17am, Wednesday, 22'nd Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biohaven Pharmaceutical Holding Co (
BHVN
–
Research Report
) and Cara Therapeutics (
CARA
–
Resear
Cara Therapeutics Inc (NASDAQ:CARA) SVP Frederique Ph.D. Menzaghi Sells 12,894 Shares of Stock
09:22am, Wednesday, 22'nd Apr 2020
Cara Therapeutics Inc (NASDAQ:CARA) SVP Frederique Ph.D. Menzaghi sold 12,894 shares of the firm’s stock in a transaction dated Tuesday, April 21st. The stock was sold at an average price of $15.58,
Cara Therapeutics (NASDAQ:CARA) Now Covered by Needham & Company LLC
07:40am, Wednesday, 22'nd Apr 2020
Needham & Company LLC assumed coverage on shares of Cara Therapeutics (NASDAQ:CARA) in a research report issued to clients and investors on Tuesday, TipRanks reports. The brokerage set a “buy” rat
Short Interest in Cara Therapeutics Inc (NASDAQ:CARA) Declines By 13.2%
06:58am, Wednesday, 22'nd Apr 2020
Cara Therapeutics Inc (NASDAQ:CARA) was the target of a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 3,690,000 shares, a decline of 13.2%
Cannabis Stock Gainers And Losers From April 21, 2020
01:04am, Wednesday, 22'nd Apr 2020
Gainers
Body and Mind (OTC: BMMJ) shares closed up 23.61% at $0.38
Cann Group (OTC: CNGGF) shares closed up 12.5% at $0.54
AusCann Group Holdings (OTC: ACNNF)...
Cara Therapeutics Itching Drug Scratches Off Goals of Phase 3 Test
08:52pm, Tuesday, 21'st Apr 2020
A Cara Therapeutics drug developed to treat the severe itching experienced by patients receiving hemodialysis has met the main goal of a second late-stage
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright CARA
04:07pm, Tuesday, 21'st Apr 2020
Cara Therapeutics price target raised to $33 from $30 at H.C. Wainwright H.C. Wainwright CARA
